Company Valuation: SMS Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026
Market Cap 1 10,518 7,915 4,931 15,089 18,863 35,105
Change - -24.75% -37.7% 206.01% 25.01% 86.1%
Enterprise Value (EV) 1 12,660 10,082 7,398 17,536 21,556 38,296
Change - -20.36% -26.62% 137.04% 22.93% 77.66%
P/E 16.8x 12.7x -69.9x 30.3x 27.3x 33.6x
PBR 2.56x 1.68x 1.07x 2.81x 2.95x 4.47x
PEG - -25.87x 1x -0x 0.8x 0.8x
Capitalization / Revenue 1.86x 1.52x 0.94x 2.13x 2.41x 3.95x
EV / Revenue 2.24x 1.94x 1.42x 2.47x 2.75x 4.31x
EV / EBITDA 10.3x 8.83x 13.7x 15x 15.5x 22.1x
EV / EBIT 12.5x 12.1x 32.5x 20.4x 20.5x 28.6x
EV / FCF -12.4x -44.8x -23.4x -70.3x -31x -41.1x
FCF Yield -8.04% -2.23% -4.27% -1.42% -3.22% -2.43%
Dividend per Share 2 0.3 0.3 0.3 0.4 0.4 0.4
Rate of return 0.24% 0.32% 0.52% 0.22% 0.19% 0.11%
EPS 2 7.386 7.35 -0.8339 5.886 7.799 11.15
Distribution rate 4.06% 4.08% -36% 6.8% 5.13% 3.59%
Net sales 1 5,651 5,199 5,221 7,093 7,827 8,886
EBITDA 1 1,227 1,142 541.8 1,169 1,387 1,735
EBIT 1 1,014 830.7 227.3 860.1 1,049 1,338
Net income 1 625.3 622.2 -70.59 498.3 691.4 1,020
Net Debt 1 2,142 2,167 2,467 2,447 2,693 3,191
Reference price 2 124.25 93.50 58.25 178.25 212.78 374.85
Nbr of stocks (in thousands) 84,652 84,652 84,652 84,652 88,652 93,652
Announcement Date 9/8/21 9/7/22 9/7/23 9/6/24 9/6/25 9/4/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
34.18x6.41x22.23x0.92% 46.37B
15.96x1.97x8.77x1.69% 37.26B
28.87x4.1x17.01x0.56% 12.53B
27.25x3.31x17.13x0.93% 11.8B
18.58x3.37x11.75x3.79% 8.97B
15.51x2.06x6.85x3.21% 7.29B
9.18x2.12x5.48x4.84% 7.09B
28.95x3.78x17.59x0.16% 7.01B
Average 22.31x 3.39x 13.35x 2.01% 17.29B
Weighted average by Cap. 24.65x 3.96x 15.11x 1.57%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock
  4. SMSPHARMA Stock
  5. Valuation SMS Pharmaceuticals Limited